Previous Close | 15.26 |
Open | 16.50 |
Bid | 18.50 |
Ask | 19.70 |
Strike | 170.00 |
Expire Date | 2025-01-17 |
Day's Range | 16.50 - 17.00 |
Contract Range | N/A |
Volume | |
Open Interest | 48 |
Zoetis stock reversed its recent bad fortune Thursday, rising after the pet-drug maker beat first-quarter expectations.
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The animal health firm has had a tough year. Shares have plunged in response to negative media reports about an important new medicine.